Current Funding

 

Cancer Prevention & Research Institute of Texas, RP160844                                           

“Center for Innovative Drug Discovery: Enhancement of a Shared Cancer Resource for South Texas”. Collaboration with UT Health San Antonio.

 

Department of Defense CDMRP, PR171296                                               

“Protein Kinase C Epsilon Inhibitors to Treat Pain”. Collaboration with UT Austin and UC San Francisco

                                        

National Institutes of Health R01 AI119554

“Development of novel chemical series of Candida albicans biofilm inhibitors”. Collaboration with Jose Lopez Ribot (UTSA).

 

National Institutes of Health R01 AI115691

“Structure-guided redesign of an antischistosomal drug”. Collaboration with UT Health San Antonio and Texas BioMed.

 

Completed Funding

 

Department of the Army, Medical Research, PR141776

“Discovery of Novel N-Nicotinamide Methyltransferase Inhibitors to Combat Obesity-Linked Osteoarthritis and Metabolic Disease among Veterans and Beneficiaries”.  Collaboration with UTMB Galveston.

 

Cancer Prevention & Research Institute of Texas, DP150055

“Druggable Targets that Regulate the Antitumor Activity of ER-beta”.  Collaboration with UT Health San Antonio.

 

IIMS/CTSA (NIH) pilot award

“Development of novel FAAH Inhibitors for the Treatment of Schizophrenia”. Collaboration with UT Health San Antonio

 

IIMS/CTSA (NIH) pilot award

 

“Discovery of novel inhibitors of oncoprotein EYA2 in breast and ovarian cancers”.  Collaboration with UT Health San Antonio.